---
document_datetime: 2025-01-16 11:36:55
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/somakit-toc-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: somakit-toc-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 17.43575
conversion_datetime: 2025-12-28 11:13:50.889226
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## SomaKit TOC

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0035               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 16/01/2025                          |                                             | PL                               |           |
| IB/0034/G            | This was an application for a group of variations.                                               | 11/12/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | the finished or intermediate product - Other variation B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.a.3.z - Changes in the composition (excipients) of the finished product - Other variation B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.3.z - Change in the manufacturing process of   |            |     |    |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|
| II/0028   | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 14/11/2024 | n/a |    |
| N/0032    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 01/10/2024 |     | PL |
| IB/0031/G | This was an application for a group of variations. B.II.c.z - Change in control of excipients in the Finished Product - Other variation B.II.c.z - Change in control of excipients in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 24/07/2024 | n/a |    |

<div style=\"page-break-after: always\"></div>

|                     | Finished Product - Other variation B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure   |            |            |                        |                                                                                                                                            |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| N/0030              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 29/05/2024 |            | PL                     |                                                                                                                                            |
| N/0029              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 19/03/2024 |            | PL                     |                                                                                                                                            |
| N/0027              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 28/09/2023 | 06/02/2024 | PL                     |                                                                                                                                            |
| PSUSA/10552 /202212 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                           | 06/07/2023 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                          |
| IB/0024             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                       | 21/02/2023 | n/a        |                        |                                                                                                                                            |
| IAIN/0025           | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                          | 13/02/2023 | 06/02/2024 | SmPC, Labelling and PL |                                                                                                                                            |
| PSUSA/10552 /202112 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                           | 21/07/2022 | 19/09/2022 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10552/202112. |

<div style=\"page-break-after: always\"></div>

| N/0023              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                | 04/05/2022   | 19/09/2022   | PL                               |                                                                                                                                                                                                                                                                           |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0019              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 16/09/2021   | 12/11/2021   | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of SomaKit TOC in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/10552 /202012 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 22/07/2021   | 16/09/2021   | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10552/202012.                                                                                                                                |
| IB/0020             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                  | 09/06/2021   | 16/09/2021   | SmPC                             |                                                                                                                                                                                                                                                                           |
| IB/0021             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                       | 06/05/2021   | 16/09/2021   | SmPC                             |                                                                                                                                                                                                                                                                           |
| IAIN/0017/G         | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished | 10/12/2020   | 16/09/2021   | Annex II and PL                  |                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|                     | the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            |             |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0015             | Update of sections 4.4, 4.5 and 4.6 of the SmPC in order to amend an existing warning extending the period during which close contact with infants and pregnant women should be restricted, add information on interactions with glucocorticosteroids and extend the period during which breastfeeding should be interrupted. The Package Leaflet is updated accordingly. Additionally, the MAH took the opportunity to update the details of local representatives. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 03/09/2020 | 16/09/2021 | SmPC and PL | Close contact with infants and pregnant women should be restricted during the first 12 hours after administration. Breastfeeding should be interrupted for 12 hours and the expressed feeds discarded. Repeated administration of high-doses of glucocorticosteroids prior to gallium (68Ga) edotreotide administration may cause insufficient SSTR2 expression for adequate visualization of somatostatin receptor-positive NETs. |
| IA/0016/G           | This was an application for a group of variations. B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                      | 28/08/2020 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| PSUSA/10552 /201912 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 09/07/2020 | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                  |
| PSUSA/10552 /201906 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 30/01/2020 | 27/03/2020 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |      | PSUSA/10552/201906.               |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| II/0011             | B.II.e.1.a.3 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 12/12/2019 | 27/03/2020 | SmPC |                                   |
| IA/0013             | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 15/10/2019 | n/a        |      |                                   |
| PSUSA/10552 /201812 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 11/07/2019 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0008/G           | This was an application for a group of variations. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting | 21/01/2019 | n/a        |      |                                   |

<div style=\"page-break-after: always\"></div>

|                     | material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data   |            |            |      |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| PSUSA/10552 /201806 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                  | 17/01/2019 | n/a        |      | PRAC Recommendation - maintenance |
| N/0009              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                           | 17/12/2018 | 01/10/2019 | PL   |                                   |
| IB/0006             | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                 | 01/10/2018 | 01/10/2019 | SmPC |                                   |
| PSUSA/10552 /201712 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                  | 12/07/2018 | n/a        |      | PRAC Recommendation - maintenance |
| PSUSA/10552 /201706 | Periodic Safety Update EU Single assessment - edotreotide                                                                                                                                                                                                                                                  | 11/01/2018 | n/a        |      | PRAC Recommendation - maintenance |
| IB/0003             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                  | 12/06/2017 | 07/06/2018 | SmPC |                                   |
| N/0002              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                           | 08/05/2017 | 07/06/2018 | PL   |                                   |
| N/0001              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                           | 05/04/2017 | 07/06/2018 | PL   |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->